Skip to main
SNWV
SNWV logo

SNWV Stock Forecast & Price Target

SNWV Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SANUWAVE Health Inc demonstrated strong financial performance in fiscal year 2024, achieving a remarkable 60% year-over-year revenue growth, totaling $32.6 million, attributed to increases in both system sales and consumables. The company also reported a significant improvement in AEBITDA, which increased by 28 points to 22%, reflecting enhanced operational efficiency and financial health. Although operating expenses rose to $6.4 million primarily due to non-cash stock-based compensation and NASDAQ fees, the overall growth metrics indicate a solid foundation for future expansion in the regenerative medicine market.

Bears say

SANUWAVE Health Inc. has demonstrated modest applicator usage decline in the first quarter compared to the fourth quarter, attributed to typical seasonal patient behavior following the annual insurance deductible reset in January, suggesting potential volatility in demand. Several financial challenges loom over the company, including margin compression, competitive pressures, diminished sales representative productivity, and potential manufacturing difficulties, all of which may hinder growth prospects. The dependence on maintaining relationships with group purchasing organizations further complicates the company's sales outlook, indicating a fragile market position that could adversely affect revenue generation.

SNWV has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SANUWAVE Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SANUWAVE Health Inc (SNWV) Forecast

Analysts have given SNWV a Buy based on their latest research and market trends.

According to 2 analysts, SNWV has a Buy consensus rating as of Nov 4, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $55, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $55, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SANUWAVE Health Inc (SNWV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.